中和抗體市場，依抗體類型，目標病毒，應用，最終用戶，配銷通路，地區

Neutralizing Antibody Market, By Antibody Type: Monoclonal Antibodies, Polyclonal Antibodies, Target Virus: SARS-CoV-2, HIV, Influenza, Ebola, Zika, Hepatitis C, Others, Application, End User, Distribution Channel, Geography

出版日期: 2023年10月30日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023年全球中和抗體市場規模為1,904.4億美元，預計2030年將達到3,388.6億美元，2023年至2030年複合年成長率為8.6%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	1904.4億美元
實績資料	2018-2021	預測期	2023-2030
預測期複合年成長率	8.60%	2030年市場規模預測	3388.6億美元

圖 1. 2023 年中和抗體的全球市場佔有率(%)（依地區）

中和抗體是先天免疫的重要組成部分，由自然感染和疫苗接種誘導。這些抗體可辨識病毒的特定部分並阻止其結合和感染細胞。由於其特殊的結構，抗體可以與病毒刺突蛋白上的受體結合域（RBD）結合，阻止其與宿主細胞受體結合，從而促進病毒進入細胞。

市場動態：

全球中和抗體市場預計在預測期內將快速成長。這種成長的主要驅動力之一是肝炎、愛滋病毒和結核病等感染疾病的高盛行率。多種治療性單株抗體的可用性也是推動市場成長的因素之一。此外，引入先進技術來開發單株抗體預計將推動該市場的成長。然而，這些測試的高成本可能會限制其採用，從而阻礙市場成長。

本研究的主要特點

本報告對全球中和抗體市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個區隔市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球中和抗體市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的資訊。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球中和抗體市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 190.44 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.60%	2030 Value Projection:	US$ 338.86 Bn

Neutralizing antibodies are a critical component of natural immunity and can be induced by both natural infection and vaccination. These antibodies recognize specific parts of the virus and prevent them from binding to and infecting cells. The antibodies' specialized structure allows them to bind to the receptor binding domain (RBD) on the viral spike protein, preventing it from engaging the host cell's receptor and facilitating virus entry into the cell.

Market Dynamics:

The global neutralizing antibody market is expected grow rapidly over the forecast period. One of the key drivers for this growth is the high prevalence of infectious diseases such as hepatitis, HIV, and tuberculosis. The availability of several therapeutic mAbs is another factor driving market growth. In addition, the introduction of advanced technologies for developing mAbs is expected to drive the growth of this market. However, the high cost of these tests can limit their adoption, thereby hindering market growth.

Key features of the study:

This report provides in-depth analysis of the global neutralizing antibody market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neutralizing antibody market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Regeneron Pharmaceuticals, Inc., Eli Lilly and Company, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi SA, Roche Holding AG, Novartis AG, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Takeda, Pharmaceutical Company Limited, Moderna, Inc., BioNTech SE, CSL Limited, and Sinovac Biotech Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neutralizing antibody market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neutralizing antibody market

Neutralizing Antibody Market Detailed Segmentation:

By Antibody Type:
- Monoclonal Antibodies
- Polyclonal Antibodies
By Target Virus:
- SARS-CoV-2 (COVID-19)
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Others
By Application:
- Therapeutics
- Diagnostics
- Research and Development
By End User:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
By Distribution Channel:
- Direct Sales to End-Users
- Distributors
- Online Retail
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Players
- Regeneron Pharmaceuticals, Inc.
- Eli Lilly and Company
- AstraZeneca PLC
- GlaxoSmithKline plc
- Sanofi SA
- Roche Holding AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Takeda Pharmaceutical Company Limited
- Moderna, Inc.
- BioNTech SE
- CSL Limited
- Sinovac Biotech Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Neutralizing Antibody, By Antibody Type
- Market Neutralizing Antibody, By Target Virus
- Market Neutralizing Antibody, By Application
- Market Neutralizing Antibody, By End User
- Market Neutralizing Antibody, By Distribution Channel
- Market Neutralizing Antibody, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- COVID-19 Pandemic
- Increasing Prevalence of Infectious Diseases
- Rising Incidence of Autoimmune Disorders
- Advancements in Biotechnology and Monoclonal Antibody Development
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Neutralizing Antibody Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Neutralizing Antibody Market , By Antibody Type, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Bn)
Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Bn)

6. Neutralizing Antibody Market , By Target Virus, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
SARS-CoV-2 (COVID-19)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Ebola
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Zika
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Hepatitis C
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

7. Neutralizing Antibody Market , By Application, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

8. Neutralizing Antibody Market , By End User, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

9. Neutralizing Antibody Market , By Distribution Channel, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Direct Sales to End-Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Online Retail
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2023,(US$ Billion)

10. Neutralizing Antibody Market , By Region, 2018-2023, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Antibody Type, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Target Virus, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2023,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2023,(US$ Bn)
GCC
Israel
North Africa
Central Africa
Rest of Middle East & Africa

11. Competitive Landscape

Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
AstraZeneca PLC
GlaxoSmithKline plc
Sanofi SA
Roche Holding AG
Novartis AG
Merck & Co., Inc.
Pfizer Inc.
Johnson & Johnson
Takeda Pharmaceutical Company Limited
Moderna, Inc.
BioNTech SE
CSL Limited
Sinovac Biotech Ltd.
Analyst Views